Flash Finance

Kronox Lab Sciences LimitedKRONOXCorporate

Chemicals Latest results: Jun 2026 14 quarters of data
₹209.15
MCap ₹776 Cr · P/E 27.2
Kronox Lab Sciences Limited — Stock analysis & AI research Kronox Lab Sciences Limited — Multibagger AI analysis Kronox Lab Sciences Limited — Seasonality — best & worst months Kronox Lab Sciences Limited — Technical setup — score, trend, support & resistance Kronox Lab Sciences Limited — Live exchange announcements
📋 High ROE Stocks📋 High ROCE Stocks📋 High Operating Margin Stocks📋 High Interest Coverage Stocks 📈 MACD Bullish Crossover📈 Strong Trend Stocks (ADX > 25)📈 Bullish EMA Alignment📈 Relative Strength Leaders📈 Multi-Timeframe Bullish Stocks📈 Stocks Above Anchored VWAP 🏭 Chemicals sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹28 Cr
Sales · Jun 2026
+16.9% YoY
₹9 Cr
Operating Profit · Jun 2026
+12.9% YoY
31.7%
OPM % · Jun 2026
-3.4% YoY
₹7 Cr
Net Profit · Jun 2026
+16.3% YoY
₹2.00
EPS · Jun 2026
+17.6% YoY

📝 Kronox Lab Sciences Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Kronox Lab Sciences Limited reported revenue of ₹28 crore for the quarter ended June 2026 (Q1 FY27), up 16.9% from ₹24 crore in the same quarter last year, and up 8.6% sequentially over the March 2026 quarter.

Net profit rose 16.3% year-on-year to ₹7 crore, from ₹6 crore. Earnings per share (EPS) came in at ₹2.00.

Operating profit stood at ₹9 crore — an operating margin (OPM) of 31.7%, compared with 32.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Kronox Lab Sciences Limited posted revenue of ₹101 crore, a growth of 1.0% over FY25, with a net profit of ₹28 crore (up 8.2% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹105 crore with a net profit of ₹29 crore.

Valuation snapshot

At the current price of ₹209.15, KRONOX has a market capitalisation of ₹776 crore and a trailing P/E of about 27.2.

Within the Chemicals industry, it is the 25th-largest of the 79 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 74.21%, foreign institutional investors (FIIs) 0.08%, domestic institutional investors (DIIs) 2.05%, public shareholders 23.66% of Kronox Lab Sciences Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹776 Cr
Current Price ?
₹209.2
P/E ?
27.16above ind
Industry P/E ?
24.60
P/B ?
6.69
P/S ?
7.37
P/FCF ?
36.95
Enterprise Value ?
₹778 Cr
EV/EBITDA ?
22.11
PEG ?
1.43
Earnings Yield ?
4.3%
Dividend Yield ?
0.23%
Profitability & Returns
Sales (TTM) ?
₹105 Cr
OPM ?
33.4%
Profit after tax (TTM) ?
₹29 Cr
EPS (TTM) ?
₹7.70
ROCE ?
36.0%
ROE ?
24.6%
ROA ?
22.3%
Growth
Sales — latest qtr ?
₹28 Cr
PAT — latest qtr ?
₹7 Cr
YoY qtr sales growth ?
16.9%
YoY qtr profit growth ?
16.3%
Sales growth (3y) ?
2%
Sales growth (5y) ?
10%
Profit growth (3y) ?
19%
Profit growth (5y) ?
23%
Financial Health
Debt ?
₹2 Cr
Debt to Equity ?
0.02
Interest Coverage ?
272.1
Current Ratio ?
N/A
Ownership
Promoter holding ?
74.21%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
37.7%
Return 6 months ?
57.6%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 2126212122252524262426252628 +16.9% +8.6%
Operating Profit 496688988898109 +12.9% -5.5%
Other Income 00001001111121 +48.5% -39.7%
Interest 00000000000000 — -17.5%
Depreciation 00000000000110 +12.8% -31.5%
Profit Before Tax 4866889988991110 +16.2% -10.6%
Net Profit 26456667667787 +16.3% -8.7%
EPS 0.661.721.171.281.601.671.761.771.721.701.821.792.162.00 +17.6% -7.4%
OPM % 18.6% 32.8% 27.9% 29.4% 35.4% 32.6% 35.4% 34.8% 29.7% 32.8% 33.9% 31.7% 36.4% 31.7% -3.4% -12.9%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹100 Cr ₹101 Cr ₹105 Cr +1.0%
Operating Profit ₹33 Cr ₹34 Cr ₹35 Cr +3.1%
OPM % 33.06% 33.74% 33.41% +2.1%
NPM % 25.42% 27.21% 27.12% +7.0%
Other Income ₹3 Cr ₹5 Cr ₹6 Cr +105.8%
Depreciation ₹1 Cr ₹2 Cr ₹2 Cr +48.3%
Interest ₹0 Cr ₹0 Cr ₹0 Cr —
EBIT ₹32 Cr ₹32 Cr ₹33 Cr +1.1%
PBT ₹34 Cr ₹37 Cr ₹39 Cr +8.5%
Tax ₹9 Cr ₹7 Cr ₹7 Cr -24.2%
Net Profit ₹25 Cr ₹28 Cr ₹29 Cr +8.2%
EPS ₹6.92 ₹7.47 ₹7.77 +7.9%
Material Cost ₹49 Cr ₹36 Cr ₹38 Cr -26.5%
Employee Cost ₹5 Cr ₹6 Cr ₹6 Cr +21.2%
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Reserves 8295379 +49.1%
Equity Capital 37373737 +0.0%
Borrowings 0002 —
Other Liabilities 98910 +11.1%
Total Liabilities 547499128 +29.3%
Fixed Assets 16262829 +3.6%
CWIP 0011 +0.0%
Investments 0000 —
Other Assets 38477098 +40.0%
Total Assets 547499128 +29.3%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 20173124 -22.6%
Cash from Investing Activity -7-17-28-24 +14.3%
Cash from Financing Activity -130-2-0 +100.0%
Net Cash Flow -000-0 —
Free Cash Flow 1152821 -25.0%
CFO/OP 117%87%120%98% -18.3%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 71727276 +5.6%
Inventory Days 61744666 +43.5%
Days Payable 52515252 +0.0%
Cash Conversion Cycle 80946690 +36.4%
Working Capital Days 8314316871 -57.7%
ROCE % 50%52%44%36% -18.2%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 74.21%74.21%74.21%74.21% +0.0%
FIIs 0.03%0.03%0.05%0.08% +60.0%
DIIs 1.71%1.93%2.00%2.05% +2.5%
Public 24.04%23.84%23.74%23.66% -0.3%
No. of Shareholders 37,56935,78034,60833,469 -3.3%

⚖️ Peer comparison

Industry: Chemicals · top 25 of 79 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 NAVINFLUOR Navin Fluorine ₹8,545.00 43,843 55.4 3,634 790 33.9% 21.7% 41.1% 130.1% 44.1% 107.7%
2 DEEPAKNTR Deepak Nitrite ₹1,596.00 21,768 27.8 8,575 784 15.5% 9.1% -4.8% -22.5% 36.4% 207.4%
3 DEEPAKFERT Deepak Fertilisers ₹1,323.00 16,718 17.0 12,103 985 16.7% 8.1% 12.0% -21.8% 22.5% 101.0%
4 TATACHEM Tata Chemicals ₹615.00 15,668 — 15,120 -1,971 11.3% -13.0% -2.0% -543.2% 14.4% -81.0%
5 PCBL PCBL Chemical ₹331.50 13,043 43.3 6,596 298 13.4% 4.5% -12.5% -46.0% 17.0% 64.8%
6 JUBLINGREA Jubilant Ingrevia ₹647.25 10,208 33.3 4,651 308 13.4% 6.6% 5.1% 10.3% 25.3% 40.9%
7 ALKYLAMINE Alkyl Amines ₹1,818.60 9,301 41.3 1,658 225 20.6% 13.5% -2.3% -3.8% 30.1% 93.1%
8 CLEAN Clean Science ₹820.00 8,715 37.4 982 232 35.7% 23.6% -2.5% -13.7% 21.9% -4.7%
9 GNFC Gujarat Narmada ₹539.75 7,931 7.6 8,410 1,037 14.8% 12.3% -1.5% 35.3% 39.8% 275.9%
10 GALAXYSURF Galaxy Surfactants ₹2,156.30 7,887 21.6 5,752 353 10.4% 6.1% 24.3% -50.0% 39.4% 108.7%
11 NEOGEN Neogen Chemicals ₹2,403.50 7,221 180.9 926 36 16.6% 3.8% 10.9% -17.6% 34.0% 66.8%
12 BALAMINES Balaji Amines ₹2,215.00 7,177 35.3 1,523 211 21.4% 13.9% 2.0% 6.5% 27.2% 113.9%
13 FCL Fineotex Chemical ₹53.07 6,180 41.6 1,012 148 16.7% 14.6% 44.8% 14.5% 174.8% 92.6%
14 ACI Archean Chemical ₹470.90 5,814 61.0 1,123 95 20.3% 8.5% 7.8% -37.0% 8.9% -24.4%
15 GULFOILLUB Gulf Oil ₹1,057.20 5,235 13.9 4,367 371 12.6% 8.5% 11.7% -3.4% 30.6% 27.0%
16 FOSECOIND Foseco India ₹6,846.50 5,186 64.7 618 77 17.5% 12.5% 12.2% -1.9% 9.2% 8.9%
17 GUJALKALI Gujarat Alkalies ₹696.50 5,115 77.0 4,497 66 11.2% 1.5% 7.0% 96.3% 12.6% 499.0%
18 LXCHEM Laxmi Organic ₹178.50 4,961 40.2 3,117 123 8.2% 4.0% -4.7% -43.4% 44.1% 194.8%
19 VISHNU Vishnu Chemicals ₹724.90 4,880 32.6 1,694 150 15.5% 8.8% 11.1% 12.2% 24.9% 23.0%
20 YASHO Yasho Industries ₹4,028.70 4,857 84.9 939 57 19.5% 6.1% 24.0% 771.1% 54.9% 801.3%
21 EPIGRAL Epigral ₹1,084.00 4,677 17.3 2,626 271 22.2% 10.3% -0.9% -7.2% 16.3% -37.9%
22 TATVA Tatva Chintan ₹1,867.60 4,369 85.0 556 51 19.3% 9.2% 32.6% 702.6% 42.8% 128.3%
23 GHCL GHCL ₹418.85 3,839 7.4 3,043 525 23.0% 17.3% -3.7% -23.5% -2.7% 31.8%
24 PREMEXPLN Premier Explosives ₹685.10 3,685 110.0 349 34 6.8% 9.6% -7.0% 60.5% -27.8% -80.2%
25 KRONOX Kronox Lab ₹173.15 642 22.3 105 29 33.4% 27.1% 1.0% 8.2% 16.9% 16.3%
❓ Frequently asked questions
What was Kronox Lab Sciences Limited's revenue in Q1 FY27?
Kronox Lab Sciences Limited reported revenue of ₹28 crore for the quarter ended June 2026 (Q1 FY27), up 16.9% from ₹24 crore in the same quarter last year, and up 8.6% sequentially over the March 2026 quarter.
What was Kronox Lab Sciences Limited's net profit in Q1 FY27?
Net profit rose 16.3% year-on-year to ₹7 crore, from ₹6 crore. Earnings per share (EPS) came in at ₹2.00.
What is KRONOX's market capitalisation and P/E ratio?
At the current price of ₹209.15, KRONOX has a market capitalisation of ₹776 crore and a trailing P/E of about 27.2.
Who owns Kronox Lab Sciences Limited? (shareholding pattern)
As of Mar 2026, promoters held 74.21%, foreign institutional investors (FIIs) 0.08%, domestic institutional investors (DIIs) 2.05%, public shareholders 23.66% of Kronox Lab Sciences Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI